BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 19449379)

  • 1. Screening and adenocarcinoma of the cervix.
    Sasieni P; Castanon A; Cuzick J
    Int J Cancer; 2009 Aug; 125(3):525-9. PubMed ID: 19449379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?
    Castanon A; Landy R; Sasieni PD
    Int J Cancer; 2016 Sep; 139(5):1040-5. PubMed ID: 27096255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. False negative rate in mass screening for cervical cancer.
    Sato S; Mikino H; Matsunaga G; Yajima A
    Acta Cytol; 1998; 42(3):836-7. PubMed ID: 9622728
    [No Abstract]   [Full Text] [Related]  

  • 4. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
    de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
    Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical screening and risk of adenosquamous and rare histological types of invasive cervical carcinoma: population based nested case-control study.
    Lei J; Andrae B; Ploner A; Lagheden C; Eklund C; Nordqvist Kleppe S; Wang J; Fang F; Dillner J; Elfström KM; Sparén P
    BMJ; 2019 Apr; 365():l1207. PubMed ID: 30944091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England.
    Sasieni P; Adams J
    Lancet; 2001 May; 357(9267):1490-3. PubMed ID: 11377601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Support for down-staging of pregnancy-associated cervical cancer.
    Kärrberg C; Rådberg T; Holmberg E; Norström A
    Acta Obstet Gynecol Scand; 2015 Jun; 94(6):654-9. PubMed ID: 25845736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of negative and low-grade cervical smears in women with invasive cervical cancer after the first 3 years of the national cervical screening programme in Slovenia.
    Repše-Fokter A; Pogačnik A; Snoj V; Primic-Žakelj M; Fležar MS
    Cytopathology; 2012 Feb; 23(1):23-9. PubMed ID: 20964743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical carcinoma in a Muslim community.
    Badar F; Anwar N; Meerza F; Sultan F
    Asian Pac J Cancer Prev; 2007; 8(1):24-6. PubMed ID: 17477766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cervical cancer in the young woman].
    Marie G; Barjot P; Crouet H; Mace-Lesech J; Dommesent D; Uzan M
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(7):743-7. PubMed ID: 8308200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of causes of increased incidence of cervical cancer in Slovenia.
    Smrkolj S; Rakar S; Mozina A; Erzen M
    Eur J Obstet Gynecol Reprod Biol; 2004 Dec; 117(2):213-21. PubMed ID: 15541860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer screening: patients understanding in major hospitals in Malaysia.
    Othman NH; Devi BC; Halimah Y
    Asian Pac J Cancer Prev; 2009; 10(4):569-74. PubMed ID: 19827871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer: prevention and treatment.
    Denny L
    Discov Med; 2012 Aug; 14(75):125-31. PubMed ID: 22935209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of opportunistic screening on squamous cell and adenocarcinoma of the cervix in Germany: A population-based case-control study.
    Tanaka LF; Schriefer D; Radde K; Schauberger G; Klug SJ
    PLoS One; 2021; 16(7):e0253801. PubMed ID: 34260601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in protection against adenocarcinoma of the cervix resulting from participation in cervical screening.
    Mitchell H; Hocking J; Saville M
    Cancer; 2003 Dec; 99(6):336-41. PubMed ID: 14681940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer: the increasing incidence of adenocarcinoma and adenosquamous carcinoma in younger women.
    Liu S; Semenciw R; Mao Y
    CMAJ; 2001 Apr; 164(8):1151-2. PubMed ID: 11338801
    [No Abstract]   [Full Text] [Related]  

  • 18. Changing incidence of invasive adenocarcinoma of the uterine cervix in East Anglia.
    Stockton D; Cooper P; Lonsdale RN
    J Med Screen; 1997; 4(1):40-3. PubMed ID: 9200062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer in young Japanese women.
    Ito T; Ishizuka T; Suzuki K; Ikoma Y; Saito J; Onuma M; Miwa T; Hashiba Y; Kuno N; Horibe N; Mizuno K; Ishikawa K; Kazeto S
    Arch Gynecol Obstet; 2000 Sep; 264(2):68-70. PubMed ID: 11045325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.
    Gunnell AS; Ylitalo N; Sandin S; Sparén P; Adami HO; Ripatti S
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2641-8. PubMed ID: 18086769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.